Literature DB >> 17284183

Prokineticin 2 depolarizes paraventricular nucleus magnocellular and parvocellular neurons.

Erik A Yuill1, Ted D Hoyda, Catharine C Ferri, Qun-Yong Zhou, Alastair V Ferguson.   

Abstract

Blind whole-cell patch-clamp techniques were used to examine the effects of prokineticin 2 (PK2) on the excitability of magnocellular (MNC), parvocellular preautonomic (PA), and parvocellular neuroendocrine (NE) neurons within the hypothalamic paraventricular nucleus (PVN) of the rat. The majority of MNC neurons (76%) depolarized in response to 10 nm PK2, effects that were eliminated in the presence of tetrodotoxin (TTX). PK2 also caused an increase in excitatory postsynaptic potential (EPSP) frequency, a finding that was confirmed by voltage clamp recordings demonstrating increases in excitatory postsynaptic current (EPSC) frequency. The depolarizing effects of PK2 on MNC neurons were also abolished by kynurenic acid (KA), supporting the conclusion that the effects of PK2 are mediated by the activation of glutamate interneurons within the hypothalamic slice. PA (68%) and NE (67%) parvocellular neurons also depolarized in response to 10 nm PK2. However, in contrast to MNC neurons, these effects were maintained in TTX, indicating that PK2 directly affects PA and NE neurons. PK2-induced depolarizations observed in PA and NE neurons were found to be concentration-related and receptor mediated, as experiments performed in the presence of A1MPK1 (a PK2 receptor antagonist) abolished the effects of PK2 on these subpopulations of neurons. The depolarizing effects of PK2 on PA and NE neurons were also shown to be abolished by PD 98059 (a mitogen activated protein kinase (MAPK) inhibitor) suggesting that PK2 depolarizes PVN parvocellular neurons through a MAPK signalling mechanism. In combination, these studies have identified separate cellular mechanisms through which PK2 influences the excitability of different subpopulations of PVN neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284183      PMCID: PMC2667317          DOI: 10.1111/j.1460-9568.2006.05293.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  49 in total

1.  Topographic organization of suprachiasmatic nucleus projection neurons.

Authors:  R K Leak; R Y Moore
Journal:  J Comp Neurol       Date:  2001-05-07       Impact factor: 3.215

2.  Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle.

Authors:  M Li; C M Bullock; D J Knauer; F J Ehlert; Q Y Zhou
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

3.  Voltage-gated currents distinguish parvocellular from magnocellular neurones in the rat hypothalamic paraventricular nucleus.

Authors:  J A Luther; J G Tasker
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

4.  Local glutamatergic and GABAergic synaptic circuits and metabotropic glutamate receptors in the hypothalamic paraventricular and supraoptic nuclei.

Authors:  J G Tasker; C Boudaba; L A Schrader
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

5.  Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway.

Authors:  E M Fitzgerald
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

6.  Anatomical demonstration of the suprachiasmatic nucleus-pineal pathway.

Authors:  R Teclemariam-Mesbah; G J Ter Horst; F Postema; J Wortel; R M Buijs
Journal:  J Comp Neurol       Date:  1999-04-05       Impact factor: 3.215

7.  Cardiorespiratory and metabolic responses to injection of bicuculline into the hypothalamic paraventricular nucleus (PVN) of conscious rats.

Authors:  E Schlenker; L Barnes; S Hansen; D Martin
Journal:  Brain Res       Date:  2001-03-23       Impact factor: 3.252

8.  Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling.

Authors:  Kwan L Ng; Jia-Da Li; Michelle Y Cheng; Frances M Leslie; Alex G Lee; Qun-Yong Zhou
Journal:  Science       Date:  2005-06-24       Impact factor: 47.728

9.  Diurnal rhythms of blood pressure, heart rate, and locomotor activity in adult and old male Wistar rats.

Authors:  B Zhang; F Sannajust
Journal:  Physiol Behav       Date:  2000 Aug-Sep

Review 10.  Electrophysiological distinctions between oxytocin and vasopressin neurons in the supraoptic nucleus.

Authors:  W E Armstrong; J E Stern
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

View more
  15 in total

Review 1.  The prokineticins: a novel pair of regulatory peptides.

Authors:  Qun-Yong Zhou
Journal:  Mol Interv       Date:  2006-12

Review 2.  The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction.

Authors:  Alastair V Ferguson; Kevin J Latchford; Willis K Samson
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

3.  Prokineticin 2 is an endangering mediator of cerebral ischemic injury.

Authors:  Michelle Y Cheng; Alex G Lee; Collin Culbertson; Guohua Sun; Rushi K Talati; Nathan C Manley; Xiaohan Li; Heng Zhao; David M Lyons; Qun-Yong Zhou; Gary K Steinberg; Robert M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

4.  Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals.

Authors:  D Maftei; V Marconi; F Florenzano; L A Giancotti; M Castelli; S Moretti; E Borsani; L F Rodella; G Balboni; L Luongo; S Maione; P Sacerdote; L Negri; R Lattanzi
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  MAP kinases couple hindbrain-derived catecholamine signals to hypothalamic adrenocortical control mechanisms during glycemia-related challenges.

Authors:  Arshad M Khan; Kimberly L Kaminski; Graciela Sanchez-Watts; Todd A Ponzio; J Brent Kuzmiski; Jaideep S Bains; Alan G Watts
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

6.  Absence of central circadian pacemaker abnormalities in humans with loss of function mutation in prokineticin 2.

Authors:  Ravikumar Balasubramanian; Daniel A Cohen; Elizabeth B Klerman; Duarte Pignatelli; Janet E Hall; Andrew A Dwyer; Charles A Czeisler; Nelly Pitteloud; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

7.  Catecholaminergic control of mitogen-activated protein kinase signaling in paraventricular neuroendocrine neurons in vivo and in vitro: a proposed role during glycemic challenges.

Authors:  Arshad M Khan; Todd A Ponzio; Graciela Sanchez-Watts; B Glenn Stanley; Glenn I Hatton; Alan G Watts
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

8.  Expression of prokineticin 2 and its receptor in the macaque monkey brain.

Authors:  Katherine J Burton; Xiaohan Li; Baoan Li; Michelle Y Cheng; Henryk F Urbanski; Qun-Yong Zhou
Journal:  Chronobiol Int       Date:  2016-01-28       Impact factor: 2.877

9.  Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions.

Authors:  Willis K Samson; Jian V Zhang; Orna Avsian-Kretchmer; Kai Cui; Gina L C Yosten; Cindy Klein; Rong-Ming Lyu; Yong Xiong Wang; Xiang Qun Chen; Jun Yang; Christopher J Price; Ted D Hoyda; Alastair V Ferguson; Xiao-bin Yuan; Jaw Kang Chang; Aaron J W Hsueh
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

10.  Prokineticin 2 regulates the electrical activity of rat suprachiasmatic nuclei neurons.

Authors:  Ping Ren; Huiping Zhang; Fang Qiu; Yu-Qiang Liu; Huaiyu Gu; Diane K O'Dowd; Qun-Yong Zhou; Wang-Ping Hu
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.